Induction Agent and Incidence of Hypotension in Heart Failure Patients Undergoing LVAD-Implantation — INTENS

Blood Pressure, Low Clinical Trial

Official title:
Induction Agent and Incidence of Hypotension in Heart Failure Patients Undergoing LVAD-Implantation

Status Not yet recruiting

Clinical Trial Summary

The induction of anesthesia is one of the most critical situations for high-risk-patients undergoing major surgery. For several reasons, it is crucial to maintain adequate blood pressure and cardiac output during this phase. This observational study aims to find out if the choice of the induction agent has a major impact on blood pressure and the use of antihypotensive drugs during the induction and the surgical procedure in heart-failure patients undergoing the implantation of a left ventricular assist device (LVAD).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04934410
Study type	Observational
Source	Heidelberg University
Contact	Adrian E Stephan, MD
Phone	004962215636107
Email	adrian.stephan@med.uni-heidelberg.de
Status	Not yet recruiting
Phase
Start date	November 1, 2021
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05143632` - Hemodynamic OptimizaTion in Sitting POsition Surgery Trial	N/A
Completed	`NCT03408301` - The Status of Autonomic Tone Before Tourniquet Deflation During Total Knee Replacement	N/A
Completed	`NCT03086694` - Goal-Directed Fluid Therapy for Patients Undergoing Oro-Maxillofacial Surgery